Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

PLoS One. 2012;7(1):e28820. doi: 10.1371/journal.pone.0028820. Epub 2012 Jan 9.

2.

Outcome reporting among drug trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

Ann Intern Med. 2010 Aug 3;153(3):158-66. doi: 10.7326/0003-4819-153-3-201008030-00006.

3.

Characteristics of published comparative effectiveness studies of medications.

Hochman M, McCormick D.

JAMA. 2010 Mar 10;303(10):951-8. doi: 10.1001/jama.2010.240. Erratum in: JAMA. 2010 Apr 7;303(13):1257.

PMID:
20215609
4.

Association of industry sponsorship to published outcomes in gastrointestinal clinical research.

Brown A, Kraft D, Schmitz SM, Sharpless V, Martin C, Shah R, Shaheen NJ.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1445-51. Epub 2006 Nov 13.

PMID:
17101295
5.

Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website.

Paul JR, Ranganathan P.

Rheumatol Int. 2012 Jun;32(6):1831-5. doi: 10.1007/s00296-011-2027-3. Epub 2011 Jul 19.

PMID:
21769487
6.

The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics.

Dunn AG, Bourgeois FT, Murthy S, Mandl KD, Day RO, Coiera E.

Clin Pharmacol Ther. 2012 Apr;91(4):685-91. doi: 10.1038/clpt.2011.279. Epub 2012 Feb 29.

PMID:
22378152
7.

Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.

Roumiantseva D, Carini S, Sim I, Wagner TH.

Contemp Clin Trials. 2013 Mar;34(2):348-55. doi: 10.1016/j.cct.2013.01.004. Epub 2013 Feb 1.

PMID:
23380028
8.

Studies of pain management in osteoarthritis: bedside to policy.

Losina E, Dervan EE, Daigle ME, Katz JN.

Osteoarthritis Cartilage. 2013 Sep;21(9):1264-71. doi: 10.1016/j.joca.2013.04.013.

9.

Limitations of evidence-based medicine: the role of experience and expert opinion.

Wenger DR.

J Pediatr Orthop. 2012 Sep;32 Suppl 2:S187-92. doi: 10.1097/BPO.0b013e318259f2ed.

PMID:
22890460
11.

Home treatment for mental health problems: a systematic review.

Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

Health Technol Assess. 2001;5(15):1-139. Review.

12.

Pediatric versus adult drug trials for conditions with high pediatric disease burden.

Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JP, Mandl KD.

Pediatrics. 2012 Aug;130(2):285-92. doi: 10.1542/peds.2012-0139. Epub 2012 Jul 23.

13.

General practice-based clinical trials in Germany - a problem analysis.

Hummers-Pradier E, Bleidorn J, Schmiemann G, Joos S, Becker A, Altiner A, Chenot JF, Scherer M; German ‘Clinical Trials in German General Practice Network’.

Trials. 2012 Nov 8;13:205. doi: 10.1186/1745-6215-13-205. Review.

14.

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ.

CMAJ. 2004 Feb 17;170(4):477-80.

15.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

16.

Factors associated with results and conclusions of trials of thiazolidinediones.

Rattinger G, Bero L.

PLoS One. 2009 Jun 8;4(6):e5826. doi: 10.1371/journal.pone.0005826.

17.

Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.

Katz KA, Karlawish JH, Chiang DS, Bognet RA, Propert KJ, Margolis DJ.

J Am Acad Dermatol. 2006 Nov;55(5):814-22. Epub 2006 Sep 14.

PMID:
17052487
18.

International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Levy AR, Mitton C, Johnston KM, Harrigan B, Briggs AH.

Pharmacoeconomics. 2010;28(10):813-30. doi: 10.2165/11536150-000000000-00000. Review.

PMID:
20831289
19.

Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.

Müller-Riemenschneider F, Damm K, Meinhard C, Bockelbrink A, Vauth C, Willich SN, Greiner W.

GMS Health Technol Assess. 2009 Dec 14;5:Doc16. doi: 10.3205/hta000078.

20.

Methodological issues in comparative effectiveness research: clinical trials.

Peduzzi P, Kyriakides T, O'Connor TZ, Guarino P, Warren SR, Huang GD.

Am J Med. 2010 Dec;123(12 Suppl 1):e8-15. doi: 10.1016/j.amjmed.2010.10.003. Review.

PMID:
21184867
Items per page

Supplemental Content

Write to the Help Desk